Sequences

Sample result

SIINFEKL, an exact peptide

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

2,028 publications in 1,357 families match these filters.

  1. T-CELL INDUCING VACCINE COMPOSITION COMBINATIONS AND USES THEREOF

    Altimmune Inc

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 19 to 26. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   19 SIINFEKL 26
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  2. US 10898555-B22021-01-26

    Cellular immunity inducing vaccine

    JAPANESE FOUNDATION FOR CANCER RESEARCH and THE JIKEI UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 157 to 164. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   157 SIINFEKL 164
    

    8 of 8 identical, no gaps.

  3. US 10899821-B22021-01-26

    Method of treating neoplasia with a multimeric IL-15 soluble fusion molecule

    Altor Bioscience LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  4. ANTIBODY BINDING PD-1 AND USE THEREOF

    NANJING LEADS BIOLABS CO., LTD

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  5. SHARED ANTIGENS

    GRITSTONE ONCOLOGY, INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    9 SIINFEKL 16
    

    8 of 8 identical, no gaps.

  6. IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS

    GRITSTONE ONCOLOGY, INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    9 SIINFEKL 16
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  7. WO 2021024742-A2021-02-11

    Method for assessing cytotoxicity

    University of Tsukuba

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  8. US 10918733-B22021-02-16

    Lipopeptide- and lipoprotein-conjugates and its use

    HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  9. EP 3774890-A12021-02-17

    METHODS AND COMPOSITIONS FOR TARGETING LIVER AND LYMPH NODE SINUSOIDAL ENDOTHELIAL CELL C-TYPE LECTIN (LSECTIN)

    UNIV CHICAGO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 14 to 21. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   14 SIINFEKL 21
    

    8 of 8 identical, no gaps.

  10. US 10933129-B22021-03-02

    Methods for administering synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte responses

    Selecta Biosciences, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  11. US 10941381-B22021-03-09

    Method of manufacturing dual-specific T-cells for use in cancer immunotherapy

    VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION, INC.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  12. ADJUVANT EFFECT OF THE TLR1/2 AGONIST DIPROVOCIM SYNERGIZES WITH CHECKPOINT-INHIBITING ANTIBODIES TO ELIMINATE DISEASE

    BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  13. US 10947283-B22021-03-16

    Core domain of annexins and uses thereof in antigen delivery and vaccination

    DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 449 to 456. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   449 SIINFEKL 456
    

    8 of 8 identical, no gaps.

  14. PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE

    TORQUE THERAPEUTICS, INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 2 to 9. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   2 SIINFEKL 9
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  15. EP 3793576-A12021-03-24

    LYSATES OF RECOMBINANT YEAST FOR INDUCING CELLULAR IMMUNE RESPONSES

    GLOBEIMMUNE INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  16. JP 2021509674-A2021-04-01

    CELL-ASSOCIATING IMMUNOLOGIC ADJUVANTS FOR TREATMENT ENHANCEMENT

    Academia Sinica,Che-Ming Jack Hu

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  17. WO 2021060440-A2021-04-01

    LYOPHILIZED COMPOSITION OF LIPID NANOPARTICLES

    NOF CORPORATION,NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  18. US 10973892-B22021-04-13

    Methods and compositions for enhancing vaccine immune responses

    Bavarian Nordic A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  19. US 10973896-B22021-04-13

    Treatment or prevention of melanoma using photochemical internalization of a melanoma antigen

    PCI Biotech AS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  20. US 10988754-B22021-04-27

    Nucleic acid molecules

    Cure Vac AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  21. US 10993999-B22021-05-04

    Materials and methods for producing improved lentiviral vector particles

    Immune DesignCorp.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  22. US 10994007-B22021-05-04

    Immunity inducer

    Saitama Medical University and SYSMEX CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 644 to 651. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   644 SIINFEKL 651
    

    8 of 8 identical, no gaps.

  23. US 10995156-B22021-05-04

    Acid-degradable and bioerodible modified polyhydroxylated materials

    The Regents of the University of California

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  24. EP 3814523-A12021-05-05

    METHODS AND COMPOSITIONS FOR REGULATING AN IMMUNE RESPONSE

    UNIV TEXAS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  25. VIRUSES WITH MODIFIED CAPSID PROTEINS

    SPYBIOTECH LTD

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   18 SIINFEKL 25
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  26. ANTIGEN FUSED PROTEIN AND USE THEREOF

    CELLEMEDY CO.,LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  27. PROTEIN CAPABLE OF BINDING TO IMMNUNE CHECKPOINT MOLECULE AND USE THEREOF

    CELLEMEDY CO.,LTD

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  28. ERAP1 MODULATORS

    GREY WOLF THERAPEUTICS LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  29. WO 2021100756-A2021-05-27

    Immune Checkpoint Inhibitory Antibody

    University of Miyazaki

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, JP 2019-209977.

  30. SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

    BAYER AG

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   18 SIINFEKL 25
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  31. CELL-BASED CANCER VACCINES AND CANCER THERAPIES

    MASSACHUSETTS INST TECHNOLOGY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  32. JP 2021514381-A2021-06-10

    ONCOLYTIC VIRUSES AS ADJUVANTS

    Turnstone Limited Partnership

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  33. VACCINE CONJUGATES

    ULTIMOVACS AB

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  34. US 11034963-B22021-06-15

    Allergen detection agents and assays

    DOTS TECHNOLOGY CORP.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  35. JP 2021515588-A2021-06-24

    Peptide Exchange Protein

    CAMBRIDGE ENTERPRISE LIMITED

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, GB 1801323.5.

  36. POLYMERIC NANOPARTICLES AS VACCINE ADJUVANTS

    THE PROVOST FELLOWS SCHOLARS AND OTHER MEMBERS OF BOARD OF TRINITY COLLEGE DUBLIN

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  37. NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

    REGENERON PHARMA

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  38. COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

    SQUIBB BRISTOL MYERS CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  39. US 11045492-B22021-06-29

    Immune-modifying nanoparticles for the treatment of inflammatory diseases

    onCour Pharma, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  40. POLYMERIC NANOPARTICLES FOR ENHANCED CANCER TREATMENT

    UNIV BELFAST

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  41. WO 2021132589-A2021-07-01

    POLYNUCLEOTIDE AND PHARMACEUTICAL COMPOSITION

    KYOWA KIRIN CO LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 30 to 37. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   30 SIINFEKL 37
    

    8 of 8 identical, no gaps.

  42. US 11053293-B22021-07-06

    Compositions and methods for targeted cytokine delivery

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  43. METHODS FOR GENERATING THERAPEUTIC DELIVERY PLATFORMS

    THE UNIVERSITY OF KANSAS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  44. ALPHAVIRUS NEOANTIGEN VECTORS AND INTERFERON INHIBITORS

    GRITSTONE BIO, INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  45. TREATMENT METHODS

    GENOCEA BIOSCIENCES, INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  46. MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES

    YEDA RES & DEV

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  47. BI-SPECIFIC CONJUGATES

    STRIKE PHARMA AB

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  48. EP 3856207-A12021-08-04

    TREATMENT METHODS

    GENOCEA BIOSCIENCES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  49. EP 3856241-A12021-08-04

    TREATMENT METHODS

    GENOCEA BIOSCIENCES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  50. COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HEPATITIS B AND D

    SVENSKA VACCINFABRIKEN PRODUKTION AB

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.